<!DOCTYPE HTML>
<!--
	Strongly Typed by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->   
<html> 
	<head>    
		<title>Program</title> 
		<meta charset="utf-8" />  
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" /> 
	</head>      
	<body class="left-sidebar is-preload"> 
		
            <div id="page-wrapper">  
			<!-- Header -->    
				<section id="header">
					<div class="container"> 
 
						     
						 
					<!-- Nav -->
							<nav id="nav"> 
								<ul>    <li><a class="icon solid fa-file" href="index.html"><span>Home</span></a></li>  
									<li><a class="icon solid fa-file" href="Program.html"><span>Program</span></a></li>        
									<li><a class="icon solid fa-home" href="Location.html"><span>Location</span></a></li>
									<li><a class="icon solid fa-cog" href="https://event.ugent.be/registration/event/2ecd3b15-db68-4351-886c-9eed3b27efe7"><span>Registration</span></a></li>
								</ul> 
							</nav>
						</div>
			
			
	          </section>
            
		</div>
		<!-- Content -->

			<!-- Post --> 
			<section id="main"> 		
			 <div class="container">
					<article class="box post">
					<h2>Program</h2> 
				<p>To be completed</p>
						
				<p>Since the publication of the addendum of the ICH E9(R1) guideline, estimands have received more attention. 
				The addendum is definitely a step in the right direction, as it emphasizes the importance of estimating an effect that answers 
				the clinical question of interest.
				However, so far, relatively little attention has been paid to the practical implementability of estimands in clinical trials, 
				difficulties in doing so and <strong>concerns about the developments surrounding estimands</strong>. 
				This seminar will host four experts from academia and the pharmaceutical industry who will give introductions and 
				perspectives on the theme. 
				Moreover, the <strong>opportunities and potential of recently developed causal inference methods</strong> will be discussed 
				and illustrated using case studies. <br/>  </p>
											
				<h2>Program</h2>  
				<p> <strong> 14h30-16h15: Talks by experts from academia and the pharmaceutical industry </strong> <br/> 
				<strong>Mouna Akacha</strong>, Novartis        <br/>  
				<strong>Jonathan Bartlett</strong>, London School of Hygiene & Tropical Medicine <br/>  
				<strong>Kelly Van Lancker</strong>, Ghent University	 <br/>  </p>
						
				<p> <strong> 16h15-16h30: Floor discussion </strong> <br/> 		
				Discussant: <strong>Stijn Vansteelandt</strong>, Ghent University		
						
				<h2>Target audience</h2>  		

					</article> 
				</div> 
			</section>
		
		<!-- Footer -->
				<section id="footer">
					<div id="copyright" class="container">
						<ul class="links"> 
							<li>&copy; Untitled. All rights reserved.</li><li>Design: <a href="http://html5up.net">HTML5 UP</a></li>
						</ul>
					</div>
			</section>
				
					
		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.dropotron.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
